| 5/15/2019 | DD | S&P lowers Evergreen Skills
|
| 5/15/2019 | BKDDHY | Moody’s lifts BioScrip, rates loan B2
|
| 3/18/2019 | BKDDHY | Moody’s might lift BioScrip
|
| 8/10/2018 | BKDDHY | S&P upgrades BioScrip
|
| 8/7/2018 | BWDDHY | BioScrip ‘confident’ it will record $75 million of EBITDA for 2018
|
| 7/30/2018 | BKDDHY | Moody’s upgrades BioScrip
|
| 8/1/2017 | BKDDHY | Moody’s ups BioScrip PDR, rates notes
|
| 7/5/2017 | BKDDHY | S&P rates BioScrip notes CCC+, CC
|
| 1/23/2017 | DD | Market Commentary: Bleeding goes on for Neiman Marcus as it sees steep declines; Avaya up; healthcare, pharma mixed
|
| 1/12/2017 | DD | Market Commentary: Valeant ‘top dog’ on most active list; Community Health swings down; Murray active; Avaya dips
|
| 1/10/2017 | BKDDHY | S&P assigns CCC+ to BioScrip facility
|
| 12/16/2016 | BKDDHY | S&P could lower BioScrip
|
| 12/14/2016 | BKDD | BioScrip aims to restructure revolver due 2018, needs $15 million cash
|
| 11/10/2016 | BKDDHY | S&P downgrades BioScrip
|
| 9/19/2016 | BKCVDDEMHY | S&P global speculative-grade default rate increases to 3.88% in July
|
| 8/15/2016 | BKDDHY | S&P: BioScrip view now stable
|
| 3/3/2016 | BKDDHY | Moody’s cuts BioScrip, loans, notes
|
| 8/11/2015 | BKDDHY | S&P cuts BioScrip, loan, notes
|
| 6/4/2015 | BKDDHY | S&P lowers BioScrip view to negative
|
| 3/5/2015 | BKDDHY | Moody’s drops BioScrip, loans
|
| 5/30/2014 | BKDDHY | S&P downgrades BioScrip
|
| 2/7/2014 | BKDD | S&P ups BioScrip loans, rates notes CCC+
|
| 2/5/2014 | BKDD | Moody's ups BioScrip loans, rates notes Caa2
|
| 4/8/2011 | BKDDHY | Moody's cuts BioScrip
|
